RESOURCES

T-POC Quantitative Testing Platform – Product Brochure

SurfaceSurvey™ – OSD Patient Questionnaire

Peer-Reviewed Article entitled “How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives“; Chester T. et al. Clinical Ophthalmology 2023 Jun 5;17:1587-1604.

Interpretation and Application of T-POC Quantitative Testing Results

T-POC Lateral Flow Reader Overview & Troubleshooting Guide

Lateral Flow Reader – Instructions for Use

Biovance 3L Ocular – Overview Sheet

Biovance 3L Ocular – Clinical Application Process

Biovance 3L Ocular – Clinical Application Process [VIDEO]

Biovance 3L Ocular – Pterygium Surgery Application Process

Biovance 3L Ocular – Glueless, Sutureless Pterygium Surgery [VIDEO]

Biovance 3L Ocular – Order Form

Biovance 3L Ocular – Insurance Verification Form

2024 Medicare Ocular Reimbursement Codes Flashcard

Biovance 3L Ocular – Benchtop Study Reprint

Biovance 3L Ocular – Case Study – Anterior Membrane Dystrophy

Peer-Reviewed Article entitled “An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study”; Mao Y. et al; J Biomed Mater Res. 2022;1–17.

Peer-Reviewed Article entitled “Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane“; Rivera-Morales P. et al; Clin Ophthal 2023:17;1967-1974. https://doi.org/10.2147/OPTH.S410452

Ophthalmology Times Article – Novel Amniotic Membrane: A Step Ahead of Other Scaffolds for Pterygia

Ophthalmology Times Article – 3-layer amniotic membrane successfully treats severe case of keratoconjunctivitis sicca

Healio Article – Biovance 3L Ocular effective in patients with chronic ocular surface disease

eyetube Video: Glueless, Sutureless Pterygium Surgery With Amniotic Membrane

Verséa is a registered trademark of Verséa Health, Inc.

©2024 Verséa Ophthalmics, Inc. All rights reserved.

https://www.versea.com/wp-content/uploads/2024/03/Versea-Ophthamics_wordmark_icon_white.png

If you would like to learn more about our Tear-based Point-of-Care (T-POC) Quantitative Testing Platform or Biovance 3L Ocular, please contact us at ophthalmics@versea.com

Subscribe to the Verséa Newsletter

Receive exclusive offers, discounts and latest industry insights, free of charge.

Subscribe to the Verséa Newsletter

Receive exclusive offers, discounts and latest industry insights, free of charge.

https://www.versea.com/wp-content/uploads/2024/01/Versea-Health_logo_white-1280x533.png

603 E Cass Street, Tampa, FL 33602

© 2024 Verséa Health, Inc. All rights reserved.

Explore Verséa

News